Ohtsuka et al. described a case of RPE during treatment with MTX and infliximab, in which both pleural effusion and joint disease were successfully treated with tocilizumab, an IL-6 inhibitor, without GCs [10]. This evidence concerns the gene IL6 and Pleural effusion.